TCT 2022 – Otsuka’s renal denervation system shines

It is rare that the performance of a medical device is better in its pivotal trial than in mid-stage studies. So pats on backs all round at Recor, the Otsuka subsidiary whose renal denervation system, Paradise, has posted substantial reductions in blood pressure in pivotal data presented at the weekend.